Centaurus Financial’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$105K Buy
+1,084
New +$102K ﹤0.01% 1087
2018
Q3
– Sell
-17
Closed -$1K – 1582
2018
Q2
$1K Buy
+17
New +$864 ﹤0.01% 2124

Other funds holding PBE

Centaurus Financial's PBE Position: Q3 2026 in Review

Centaurus Financial opened a new position in Invesco Biotechnology & Genome ETF (PBE) in Q3 2026: 1,084 shares worth $105K. The stake represents ﹤0.01% of the portfolio and ranks #1087 among its holdings. This is a return to the name: Centaurus Financial previously reported a position in PBE as recently as Q2 2018.

Centaurus Financial first reported a position in PBE in Q2 2018 and has held it in 2 quarters since. 122 funds tracked by Wall St. Rank hold PBE as of Q3 2026.

  • Centaurus Financial held 1,084 shares of Invesco Biotechnology & Genome ETF worth $105K as of Q3 2026.
  • Invesco Biotechnology & Genome ETF was a new Centaurus Financial position in Q3 2026.
  • Invesco Biotechnology & Genome ETF made up ﹤0.01% of Centaurus Financial's portfolio in Q3 2026, its #1087 holding.
  • Centaurus Financial first reported a position in Invesco Biotechnology & Genome ETF in Q2 2018 and has held it in 2 quarters since.
  • 122 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q3 2026.

Based on Centaurus Financial's 13F filing for Q3 2026, filed 12 Nov 2026.